As advances in treatment allow people to live longer with HIV/AIDS, resistance to certain drugs is becoming a bigger issue. Lisa Cruz is Community Liaison for Tiobtec Therapeutics specializes in virology, and particularly in HIV/AIDS medication, will discuss  “Treatment Experienced Patients: What you need to know” at the HIV Forum on Tuesday, April 10, 2007. The forum will take place from 12:00 to 1:30 pm at The Institute for Community Research (ICR), 2 Hartford Square West (146 Wyllys St.), Suite 100 in Hartford. The event is free; lunch will be provided and advance registration is required.

“I will be covering basic information around HIV Resistance and what it means to patients,” says Cruz. Cruz will discuss HIV medication and issues around resistance to HIV/AIDS drugs. Visitors should walk away with a better understanding of long-term HIV Treatment and what that means for consumers and providers. Clients, treatment counselors, case managers, outreach workers, researchers, clinicians, consumers, and others interested in drug resistance are particularly encouraged to attend.

This is the third presentation in the Spring, 2007 series of forums organized by The Institute for Community Research and the Connecticut AIDS Education and Training Center with support from Gilead Sciences, GlaxoSmithKline and Boehringer Ingelheim. The Hartford HIV Forum meets from 12:00 noon to 1:30 p.m., on the second Tuesday of each month from September through June. The goal of the forums is to give the local community the most up-to-date information on current topics in AIDS prevention, treatment, research and care. To register for the forum, call the Institute for Community Research at 860-278-2044. For more information about the series, contact Kim Radda at The Institute for Community Research at 860-278-2044 X285.

###